Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Jing-yuan-kang Granule in the Treatment of Lung Adenocarcinoma

NCT04482829 is registered in ClinicalTrials.gov with Henan University of Traditional Chinese Medicine as lead sponsor.

NCT NCT04482829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04482829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Jing-yuan-kang Granule in the Treatment of Lung Adenocarcinoma
Lead sponsor
Henan University of Traditional Chinese Medicine
Phase
Not applicable
Overall status
Unknown status
Start date
September 15, 2020
Completion date
June 30, 2022
Enrollment
144 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lung adenocarcinoma